August 2023

August 23, 2023

STATEMENT BY JUUL LABS ON LATEST RESTRUCTURING ANNOUNCEMENT

Today, JLI is announcing a company restructuring aimed at reducing our operating costs and positioning us to continue to advance our mission during a…

July 2023

July 19, 2023

A TECHNOLOGICAL SOLUTION FOR PUBLIC-HEALTH PROBLEMS: JUUL LABS SUBMITS THE FIRST PMTA FOR ITS NEXT-GENERATION PLATFORM TO IMPROVE ADULT-SMOKER SWITCHING AND RESTRICT UNDERAGE ACCESS

Juul Labs today announced the submission of the first Premarket Tobacco Product Application (PMTA) for the company’s next-generation vapor platform to the U.S. Food and Drug Administration (FDA).

April 2023

April 17, 2023

STATEMENT BY JUUL LABS ON SETTLEMENT WITH MINNESOTA ATTORNEY GENERAL

Resolution of issues from the company’s past and its historical legal challenges has remained a critical priority to secure certainty for our future. While…

April 12, 2023

STATEMENT BY JUUL LABS ON SETTLEMENT WITH SEVEN STATES

This settlement with seven state attorneys general represents another critical part in our ongoing commitment to resolve issues from the company’s past. The terms…

April 10, 2023

STATEMENT BY JUUL LABS ON SETTLEMENT WITH WEST VIRGINIA ATTORNEY GENERAL

This settlement with the West Virginia Attorney General represents yet another step in Juul Labs’ ongoing commitment to resolve issues from the company’s past….

March 2023

March 3, 2023

JUUL LABS STATEMENT ON ALTRIA’S RETURN OF SHARES

The return of Altria’s equity stake and termination of underlying agreements affords us full strategic freedom – we are no longer limited by the…

December 2022

December 6, 2022

JUUL LABS REACHES GLOBAL RESOLUTION IN U.S. LITIGATION

As of today, Juul Labs has reached settlements with plaintiffs in the federal multidistrict litigation (MDL) and related “JUUL Labs Product Cases” (JCCP) that…

October 2022

October 21, 2022

JUUL LABS PUBLISHES ITS 10.75 APPEAL, DETAILING THE SUBSTANTIVE AND PROCEDURAL ERRORS IN FDA’S MARKETING DENIAL ORDER FOR JUUL PRODUCTS AND BASIS FOR RESCISSION

Today, Juul Labs, Inc. (JLI) posted its administrative appeal of the marketing denial order (MDO) issued by the Food and Drug Administration (FDA), which…

September 2022

September 29, 2022

JOE MURILLO DELIVERS REMARKS AT 2022 GLOBAL TOBACCO & NICOTINE FORUM

Joe Murillo delivers keynote remarks at the Global Tobacco & Nicotine Forum 2022.

September 6, 2022

STATEMENT BY JUUL LABS ON MULTISTATE SETTLEMENT

This settlement with 34 states and territories is a significant part of our ongoing commitment to resolve issues from the past. The terms of…